Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM.
about
Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats,Leptin and the adrenal gland.Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy micePerceived stress scores among Saudi students entering universities: a prospective study during the first year of university life.Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesityInteractions of the circadian CLOCK system and the HPA axisA novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.Ketoconazole enantiomer for the treatment of diabetes mellitus.Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in miceLiver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissueRelative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan.The relation of thyroid function to components of the metabolic syndrome in Korean men and women.Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasisPsychobiology of depression/distress in congestive heart failureOrganization and Integration of the Endocrine System.Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposityProtopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells.Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.Cushing’s disease and melancholia.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Changes in hypothalamus-pituitary-adrenal axis following transient ischemic attack.Cushing's syndrome: a model for sarcopenic obesity.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.The N363S polymorphism in the glucocorticoid receptor gene: effects on visceral fat assessed by abdominal computed tomography.Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.Hypothalamic-Pituitary-Adrenal Axis Function and the Metabolic Syndrome X of ObesityDecreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder
P2860
Q29249076-9A51CE42-E863-4668-AA9B-571830393571Q30662008-81225CE9-ABDB-4205-9A23-6BD6F1FCC39DQ33319513-25162011-51B2-415E-B318-A90A73AF2532Q33627856-0CD7FF9B-1954-48D6-8353-C0F715F01B9EQ33641373-57F051A6-9EA5-4434-BD8C-3DE857CEA661Q33823325-65EBACAD-AADA-4804-AE44-CDDBBC33EE4AQ34023395-518296B9-CAD1-451A-A220-4BED9704B840Q34090860-47F488AE-53E0-4D9B-B9DB-CF28A0EBD7ECQ34197837-D60D9C12-5C73-4A09-8268-8E0231E60897Q34211621-691D8926-B234-4409-86AF-CF5BEBF07FC4Q34221912-97C39F30-38ED-46E6-96D5-E5868EB3B481Q34700059-AB679D2A-A89A-4956-83B8-508F01B6E029Q34753410-2F494967-0280-4F14-945B-F768CF4F7AD7Q34799650-EF81B29E-22CF-4F64-B80C-3FD2FA073683Q34962631-1EC0B1C7-B96D-43EA-8BBA-61382A065AE5Q35293910-48165A3F-EC3A-4FA5-9412-DDF19B79FE55Q36248099-D655F696-3B45-47A7-8A7F-6B2FDFB1D709Q36331122-5CE0B462-C21F-4871-8C4A-BED223D34315Q37146798-6BA73D18-F7A7-4E51-ABC6-53D6C0A18878Q37230732-3D13AC26-D039-4D36-AF4C-22E9E0941490Q37373896-A2A85F85-A0D2-4BB1-B3B0-BAE8B293322CQ37468762-01A3EAEE-5092-4B1F-8720-C70B1309F6F3Q37995205-8DF930EA-A5DF-4BE4-9A87-82E7A329EBEDQ38015162-63BA7BB0-89E8-4075-96CA-B58779E2205BQ38142904-FFAF6FE7-343E-464C-8380-018D6A2ADD78Q38681552-DB0B488A-6654-43A1-B1AB-B0FB31B1EFB1Q38683309-5EB3CEA2-FC79-4D03-A0E2-F3BB737785E9Q39416778-FBE70467-BA2F-47B1-B650-DDE7A09D1ED0Q42161031-BFA4E410-03C8-4B9D-A2F8-3DEC8CB84DB2Q45998492-47EA9FCC-5889-4004-85F7-E1E2D07172AEQ46493623-15CABB65-5E99-423F-A9F9-B0E27261B0DBQ56092439-C6FF40F8-F140-4DAD-B673-4B4A77A5506AQ58326240-D81658DE-FD42-4F2A-A18F-9FABFAF1B335
P2860
Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@en
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@nl
type
label
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@en
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@nl
prefLabel
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@en
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@nl
P2093
P356
P1433
P1476
Carbohydrate and lipid metabol ...... etabolic syndrome X and NIDDM.
@en
P2093
Chrousos GP
Costello R
Friedman TC
Mastorakos G
Papadopoulos NM
P304
P356
10.1507/ENDOCRJ.43.645
P577
1996-12-01T00:00:00Z